Fund Holdings — Camber Capital Management LP

Total Portfolio Value
$1.60B
Total Bought
$913.38M
Total Sold
$646.99M
Net Transaction
+$266.39M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ZIMMER BIOMET HOLDINGS INC(ZBH)1,605,0002,250,000+645,000170254,65515.89%+254,485
BAXTER INTL INC4,625,0005,750,000+1,125,000135196,82312.28%+196,688
HUMANA INC(HUM)650,000725,000+75,000165191,83511.97%+191,670
CVS HEALTH CORP(CVS)3,000,0002,250,000-750,000135152,4389.51%+152,303
GLOBUS MED INC(GMED)1,225,0001,250,000+25,00010191,5005.71%+91,399
PTC THERAPEUTICS INC(PTCT)3,200,0001,500,000-1,700,00014476,4404.77%+76,296
THE CIGNA GROUP(CI)150,000200,000+50,0004165,8004.11%+65,759
VIATRIS INC(VTRS)15,000,0007,500,000-7,500,00018765,3254.08%+65,138
PFIZER INC(PFE)5,000,0002,500,000-2,500,00013363,3503.95%+63,217
QIAGEN NV(QGEN)01,400,000+1,400,000056,2103.51%+56,210
ASCENDIS PHARMA A/S(ASND)800,000350,000-450,00011054,5513.40%+54,441
SAREPTA THERAPEUTICS INC(SRPT)1,000,000800,000-200,00012251,0563.19%+50,934
BROOKDALE SR LIVING INC(BKD)13,935,0006,250,000-7,685,0007039,1252.44%+39,055
BIOMARIN PHARMACEUTICAL INC(BMRN)450,000500,000+50,0003035,3452.21%+35,315
CONCENTRA GROUP HOLDINGS PAR(CON)3,500,0001,600,000-1,900,0006934,7202.17%+34,651
EVOLENT HEALTH INC(EVH)4,000,0003,000,000-1,000,0004528,4101.77%+28,365
IONIS PHARMACEUTICALS INC(IONS)625,000725,000+100,0002221,8731.36%+21,851
MYRIAD GENETICS INC(MYGN)3,100,0002,350,000-750,0004320,8451.30%+20,802
ZIMVIE INC2,725,0001,885,000-840,0003820,3581.27%+20,320
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)441,000441,00002417,2301.08%+17,206
DENALI THERAPEUTICS INC(DNLI)2,250,0001,250,000-1,000,0004616,9941.06%+16,948
ANAPTYSBIO INC1,250,000750,000-500,0001713,9430.87%+13,926
THERAVANCE BIOPHARMA INC(TBPH)1,000,0001,000,000098,9300.56%+8,921
10X GENOMICS INC(TXG)1,000,0001,000,0000148,7300.54%+8,716
INOGEN INC(INGN)2,000,000975,000-1,025,000186,9520.43%+6,933
STRUCTURE THERAPEUTICS INC300,000300,000085,1930.32%+5,185
ORASURE TECHNOLOGIES INC(OSUR)4,250,000900,000-3,350,000153,0330.19%+3,018
GENMAB A/S(GMAB)50,00050,000019790.06%+978
MERUS N V250,0000-250,000110—-11
BROOKDALE SR LIVING INC(BKD)250,0000-250,000170—-17
HERBALIFE LTD(HLF)3,000,0000-3,000,000200—-20
MEDPACE HLDGS INC(MEDP)125,0000-125,000420—-42
ALKERMES PLC(ALKS)1,500,0000-1,500,000430—-43
QIAGEN NV(QGEN)1,500,0000-1,500,000670—-67
GSK PLC(GSK)2,500,0000-2,500,000850—-85
JAZZ PHARMACEUTICALS PLC(JAZZ)1,150,0000-1,150,0001420—-142
MEDTRONIC PLC(MDT)2,750,0000-2,750,0002200—-220
Page 1 of 1
Camber Capital Management LP — 13F Holdings — Q1 2025 | TickerTrail